- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/02 - 1,2-OxazinesHydrogenated 1,2-oxazines
Patent holdings for IPC class C07D 265/02
Total number of patents in this class: 50
10-year publication summary
|
3
|
1
|
2
|
4
|
2
|
3
|
1
|
4
|
5
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1362 |
6 |
| Bayer Schering Pharma AG | 384 |
5 |
| BioMarin Pharmaceutical Inc. | 374 |
4 |
| Syngenta Crop Protection AG | 6074 |
3 |
| Adeka Corporation | 1365 |
3 |
| Nihon Nohyaku Co., Ltd. | 327 |
3 |
| Novartis AG | 10744 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 656 |
2 |
| Paratek Pharmaceuticals, Inc. | 111 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Abbott Laboratories | 2402 |
1 |
| Japan Science and Technology Agency | 1321 |
1 |
| Chlorion Pharma, Inc. | 3 |
1 |
| Enanta Pharmaceuticals, Inc. | 429 |
1 |
| FMC Corporation | 845 |
1 |
| Howard University | 189 |
1 |
| Kyowa Hakko Kirin Co., Ltd. | 280 |
1 |
| Mintz Levin Cohn Ferris Glovsky and Popeo PC | 11 |
1 |
| Nanjing Cavendish Bio-Engineering Technology Co., Ltd. | 15 |
1 |
| Promega Corporation | 574 |
1 |
| Other owners | 9 |